Biliverdin Protects against Liver Ischemia Reperfusion Injury in Swine

DSpace/Manakin Repository

Biliverdin Protects against Liver Ischemia Reperfusion Injury in Swine

Citable link to this page

 

 
Title: Biliverdin Protects against Liver Ischemia Reperfusion Injury in Swine
Author: Andria, Barbara; Bracco, Adele; Attanasio, Chiara; Castaldo, Sigismondo; Cerrito, Maria Grazia; Cozzolino, Santolo; Di Napoli, Daniele; Giovannoni, Roberto; Mancini, Antonio; Musumeci, Antonino; Mezza, Ernesto; Nasti, Mario; Scuderi, Vincenzo; Staibano, Stefania; Lavitrano, Marialuisa; Otterbein, Leo E.; Calise, Fulvio

Note: Order does not necessarily reflect citation order of authors.

Citation: Andria, B., A. Bracco, C. Attanasio, S. Castaldo, M. G. Cerrito, S. Cozzolino, D. Di Napoli, et al. 2013. “Biliverdin Protects against Liver Ischemia Reperfusion Injury in Swine.” PLoS ONE 8 (7): e69972. doi:10.1371/journal.pone.0069972. http://dx.doi.org/10.1371/journal.pone.0069972.
Full Text & Related Files:
Abstract: Ischemia reperfusion injury (IRI) in organ transplantation remains a serious and unsolved problem. Organs that undergo significant damage during IRI, function less well immediately after reperfusion and tend to have more problems at later times when rejection can occur. Biliverdin has emerged as an agent that potently suppress IRI in rodent models. Since the use of biliverdin is being developed as a potential therapeutic modality for humans, we tested the efficacy for its effects on IRI of the liver in swine, an accepted and relevant pre-clinical animal model. Administration of biliverdin resulted in rapid appearance of bilirubin in the serum and significantly suppressed IRI-induced liver dysfunction as measured by multiple parameters including urea and ammonia clearance, neutrophil infiltration and tissue histopathology including hepatocyte cell death. Taken together, our findings, in a large animal model, provide strong support for the continued evaluation of biliverdin as a potential therapeutic in the clinical setting of transplantation of the liver and perhaps other organs.
Published Version: doi:10.1371/journal.pone.0069972
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726748/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:11855906
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters